These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33837479)

  • 1. A case of a rosette-forming glioneuronal tumor with clinicopathological features of a dysembryoplastic neuroepithelial tumor and fibroblast growth factor receptor 1 internal tandem duplication.
    Uchiyama T; Gomi A; Nobusawa S; Fukushima N; Matsubara D; Kawai K
    Brain Tumor Pathol; 2021 Jul; 38(3):250-256. PubMed ID: 33837479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant transformation of a dysembryoplastic neuroepithelial tumor verified by a shared copy number gain of the tyrosine kinase domain of FGFR1.
    Matsumura N; Natsume A; Maeda S; Aoki K; Yamazaki T; Nobusawa S; Yokoo H
    Brain Tumor Pathol; 2020 Apr; 37(2):69-75. PubMed ID: 32297014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
    Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
    Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peculiar histopathological form of dysembryoplastic neuroepithelial tumor with separated pilocytic astrocytoma and rosette-forming glioneuronal tumor components.
    Matyja E; Grajkowska W; Kunert P; Marchel A
    Neuropathology; 2014 Oct; 34(5):491-8. PubMed ID: 24735014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy.
    Halfpenny A; Ferris SP; Grafe M; Woltjer R; Selden N; Nazemi K; Perry A; Solomon DA; Gultekin SH; Moore S; Olson S; Lawce H; Lucas L; Corless CL; Wood MD
    Neuropathology; 2019 Oct; 39(5):389-393. PubMed ID: 31435988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
    Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
    Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intractable epilepsy due to a rosette-forming glioneuronal tumor with a dysembryoplastic neuroepithelial background.
    Sumitomo N; Ishiyama A; Shibuya M; Nakagawa E; Kaneko Y; Takahashi A; Otsuki T; Kakita A; Saito Y; Sato N; Sugai K; Sasaki M
    Neuropathology; 2018 Jun; 38(3):300-304. PubMed ID: 29250844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors.
    Matsumura N; Nobusawa S; Ito J; Kakita A; Suzuki H; Fujii Y; Fukuda M; Iwasaki M; Nakasato N; Tominaga T; Natsume A; Mikami Y; Shinojima N; Yamazaki T; Nakazato Y; Hirato J; Yokoo H
    J Neurooncol; 2019 May; 143(1):27-33. PubMed ID: 30825062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed glioneuronal tumor: a dysembryoplastic neuroepithelial tumor with rosette-forming glioneuronal tumor component.
    Xiong J; Ding L; Chen H; Chen H; Wang Y
    Neuropathology; 2013 Aug; 33(4):431-5. PubMed ID: 23163721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CA mutation in a mixed dysembryoplastic neuroepithelial tumor and rosette forming glioneuronal tumor, a case report and literature review.
    Eye PG; Davidson L; Malafronte PJ; Cantrell S; Theeler BJ
    J Neurol Sci; 2017 Feb; 373():280-284. PubMed ID: 28131206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioneuronal tumours with features of rosette-forming glioneuronal tumours of the fourth ventricle and dysembryoplastic neuroepithelial tumours: a report of three cases.
    Chen SY; Wang W; Wang LM; Lin QT; Zhao GG; Xu G; Lu DH; Piao YS
    Histopathology; 2016 Feb; 68(3):378-87. PubMed ID: 26040650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genetic characterization of rosette-forming glioneuronal tumors: independent component analysis by tissue microdissection.
    Kitamura Y; Komori T; Shibuya M; Ohara K; Saito Y; Hayashi S; Sasaki A; Nakagawa E; Tomio R; Kakita A; Nakatsukasa M; Yoshida K; Sasaki H
    Brain Pathol; 2018 Jan; 28(1):87-93. PubMed ID: 27893178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multifocal Glioneuronal Tumor with RGNT-Like Morphology Occupying the Supratentorial Ventricular System and Infiltrating the Brain Parenchyma.
    Morassi M; Vivaldi O; Cobelli M; Liserre B; Zorzi F; Bnà C
    World Neurosurg; 2020 Jan; 133():196-200. PubMed ID: 31606508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An epilepsy-associated glioneuronal tumor with mixed morphology harboring FGFR1 mutation.
    Yamada S; Nobusawa S; Yamazaki T; Teranishi T; Watanabe S; Murayama K; Ohba S; Okabe A; Sakurai K; Urano M; Tsukamoto T; Yokoo H; Hirose Y; Abe M
    Pathol Int; 2019 Jun; 69(6):372-377. PubMed ID: 31218776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumours.
    Appay R; Bielle F; Sievers P; Barets D; Fina F; Boutonnat J; Adam C; Gauchotte G; Godfraind C; Lhermitte B; Maurage CA; Meyronet D; Mokhtari K; Rousseau A; Tauziède-Espariat A; Tortel MC; Uro-Coste E; Burel-Vandenbos F; Chotard G; Pesce F; Varlet P; Colin C; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12813. PubMed ID: 35293634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of rosette-forming glioneuronal tumors.
    Liu J; Lin F; Sun Y; Liu X
    Diagn Pathol; 2024 Feb; 19(1):39. PubMed ID: 38388383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment of oligodendrocyte precursor phenotypes in subsets of low-grade glioneuronal tumours.
    Duan Z; Feng J; Guan Y; Li S; Wu B; Shao Y; Ma Z; Hu Z; Xiang L; Zhu M; Fan X; Qi X
    Brain Commun; 2024; 6(3):fcae156. PubMed ID: 38764775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncommon Glioneuronal Tumors: A Radiologic and Pathologic Synopsis.
    Vaz A; Cavalcanti MS; da Silva Junior EB; Ramina R; de Almeida Teixeira BC
    AJNR Am J Neuroradiol; 2022 Aug; 43(8):1080-1089. PubMed ID: 35512827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.
    Siegfried A; Cances C; Denuelle M; Loukh N; Tauber M; Cavé H; Delisle MB
    Am J Med Genet A; 2017 Apr; 173(4):1061-1065. PubMed ID: 28328117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell?
    Matsumura N; Yokoo H; Mao Y; Yin W; Nakazato Y
    Neuropathology; 2013 Jun; 33(3):246-55. PubMed ID: 23025580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.